Alan Barnicle

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Institutions

• Memorial Sloan Kettering Cancer Center16.3%
• AstraZeneca (United Kingdom)13.5%
• Institute of Cancer Research8.5%
• Vall d'Hebron Institute of Oncology7.7%
• Institut Curie6.5%
• Université Paris-Saclay5.2%
• Other42.3%

Fields

• Medicine67.8%
• Biochemistry, Genetics and Molecular Biology29.4%
• Computer Science1.9%
• Chemistry0.5%
• Immunology and Microbiology0.5%

Topics

• PARP inhibition in cancer therapy22.9%
• Prostate Cancer Treatment and Research13.1%
• Advanced Breast Cancer Therapies8.6%
• PI3K/AKT/mTOR signaling in cancer7.5%
• DNA Repair Mechanisms7.2%
• Prostate Cancer Diagnosis and Treatment6.8%
• Other33.9%